Last reviewed · How we verify
Stool collection or fecal swab
At a glance
| Generic name | Stool collection or fecal swab |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV) (NA)
- Oral Aromatase Inhibitors Modify the Gut Microbiome
- Nasopharyngeal Carriage of S. Pneumoniae (NA)
- Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease (PHASE1)
- Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
- The APS Phenotyping Study
- Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease
- Healthy Volunteers Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stool collection or fecal swab CI brief — competitive landscape report
- Stool collection or fecal swab updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI